In vivo, knockout of LGMN gene from two animal models of AD, the 5XFAD and APP/PS1 mice, markedly decreased Aβ deposits and alleviated neuronal damage as well as cognitive decline [47]. The gene discussed is APP; the disease is Alzheimer disease.